Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s DiseaseRoland W. Bürli, Celia Dominguez, Dawn Yates et al.|Journal of Medicinal Chemistry|2013Cited by 149
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s DiseaseLongbin Liu, Ignacio Muñoz-Sanjuán, Karine Malagu et al.|Journal of Medicinal Chemistry|2023Cited by 7